Clinical association between pharmacogenomics and adverse drug reactions (Q38431150)

3 September 2017

1 reference

title

Clinical association between pharmacogenomics and adverse drug reactions (English)

1 reference

3 September 2017

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25895462%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Zhi-Wei Zhou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25895462%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Xiao-Wu Chen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25895462%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Kevin B Sneed

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25895462%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Yin-Xue Yang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25895462%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Zhi-Xu He

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25895462%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Kevin Chow

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25895462%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Tianxin Yang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25895462%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Wei Duan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25895462%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Shu-Feng Zhou

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25895462%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

publication date

1 April 2015

1 reference

3 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25895462%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25895462%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25895462%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

589-631

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25895462%20AND%20SRC:MED&resulttype=core&format=json

Pharmacogenomics of adverse drug reactions

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Incidence of Adverse Drug Events and Medication Errors in Japan: the JADE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Pharmacogenomics--drug disposition, drug targets, and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Pharmacogenetics and adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

The cloned butyrylcholinesterase (BCHE) gene maps to a single chromosome site, 3q26

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

HLA and pharmacogenetics of drug hypersensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Membrane transporters in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Pharmacogenomics: the genetics of variable drug responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

The effect of genetic polymorphism of cytochrome P450 CYP2C9 on phenytoin dose requirement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Contributions of CYP2C9/CYP2C19 genotypes and drug interaction to the phenytoin treatment in the Korean epileptic patients in the clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Clinical relevance of genetic polymorphisms in the human CYP2C subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Clinical relevance of genetic polymorphisms in the human CYP2C9 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Pharmacogenomics of clopidogrel: evidence and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Correlation of inter-individual variations of amitriptyline metabolism examined in hairs with CYP2C19 and CYP2D6 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

CYP2D6 genotyping and codeine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

CYP2D6 polymorphisms and the impact on tamoxifen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Severe acute cardiomyopathy associated with venlafaxine overdose and possible role of CYP2D6 and CYP2C19 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Influence of sex and CYP2D6 genotype on mirtazapine disposition, evaluated in Spanish healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

The impact of CYP2D6 genotypes on the plasma concentration of paroxetine in Japanese psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Amitriptyline or not, that is the question: pharmacogenetic testing of CYP2D6 and CYP2C19 identifies patients with low or high risk for side effects in amitriptyline therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Pharmacogenomics of phase II metabolizing enzymes and drug transporters: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Gene expression variability in human hepatic drug metabolizing enzymes and transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Functional G1199A ABCB1 polymorphism may have an effect on cyclosporine blood concentration in renal transplanted patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Genetic susceptibility to adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

SLCO1B1 variants and statin-induced myopathy--a genomewide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

SLCO1B1 Polymorphisms and Statin-Induced Myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Pharmacogenetics of OPRM1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human μ-opioid receptor (OPRM1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

µ-opioid receptor gene variant OPRM1 118 A>G: a summary of its molecular and clinical consequences for pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Beta-2 adrenergic receptor (ADRB2) gene polymorphisms and the risk of asthma: a meta-analysis of case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

β2-adrenergic receptor gene polymorphisms in normal and asthmatic individuals in the Eastern Province of Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

21 January 2018

Drug-Induced Arrhythmia

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

New mechanism contributing to drug-induced arrhythmia: rescue of a misprocessed LQT3 mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Drug-induced arrhythmia: pharmacogenomic prescribing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Novel rare variants in congenital cardiac arrhythmia genes are frequent in drug-induced torsades de pointes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

A common polymorphism associated with antibiotic-induced cardiac arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Torsade de pointes induced by cisapride/clarithromycin interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Genome-wide association studies in pharmacogenomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Using genome-wide association studies to identify genes important in serious adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Genome-wide association study: a useful tool to identify common genetic variants associated with drug toxicity and efficacy in cancer pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Cancer pharmacogenomics: strategies and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

The SLCO1B1*5 genetic variant is associated with statin-induced side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Pharmacogenomics of the RNA world: structural RNA polymorphisms in drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Genome-wide association study of SSRI/SNRI-induced sexual dysfunction in a Japanese cohort with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Genome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

HLA-A31 strongly associates with carbamazepine-induced adverse drug reactions but not with carbamazepine-induced lymphocyte proliferation in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

New genetic associations in thiopurine-related bone marrow toxicity among inflammatory bowel disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Genome-wide study of methotrexate clearance replicates SLCO1B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

HLA-B*13:01 and the dapsone hypersensitivity syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Genome-wide association study in NSAID-induced acute urticaria/angioedema in Spanish and Han Chinese populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Genetic variants associated with phenytoin-related severe cutaneous adverse reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Genome-wide association study of serious blistering skin rash caused by drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-015-0375-0

Tramadol efficacy in patients with postoperative pain in relation to CYP2D6 and MDR1 polymorphisms

21 January 2018

1 reference

12 December 2020

CYP2C9 polymorphism in patients with epilepsy: genotypic frequency analyzes and phenytoin adverse reactions correlation

1 reference

12 December 2020

Current status of clopidogrel pharmacogenomics

1 reference

12 December 2020

Genome scan implicates adhesion biological pathways in secondary leukemia

1 reference

12 December 2020

Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety

1 reference

12 December 2020

Pharmacogenomics of statin response

1 reference

12 December 2020

Association of CYP2C9 gene polymorphism with bleeding as a complication of warfarin therapy

1 reference

12 December 2020

Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients

1 reference

12 December 2020

Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis

1 reference

12 December 2020

The hemolytic effect of primaquine and related compounds: a review

1 reference

12 December 2020

KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome

1 reference

12 December 2020

Mobilizing pharmacogenomic analyses during clinical trials in drug development

1 reference

12 December 2020

Identification of genetic variants associated with capecitabine-induced hand-foot syndrome through integration of patient and cell line genomic analyses

1 reference

12 December 2020

MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects

1 reference

12 December 2020